PIK-294 is primarily used as a selective inhibitor of PI3Kγ (phosphoinositide 3-kinase gamma), making it a valuable tool in immunological and inflammatory research. It is applied in studies targeting immune cell signaling, particularly in models of inflammation and autoimmune diseases. Due to its specificity, PIK-294 helps researchers dissect the role of PI3Kγ in leukocyte activation, migration, and chemokine signaling without significantly affecting other PI3K isoforms. It has also been utilized in cancer research to investigate the tumor microenvironment, especially the function of myeloid-derived suppressor cells and tumor-associated macrophages that rely on PI3Kγ for immunosuppressive activity. Its application supports the development of targeted therapies aiming to modulate immune responses in cancer and chronic inflammatory conditions.